Found 16 matching trials
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC PHASE2 The purpose of this study is to evaluate the safety, efficacy, and PK of Vi...
Show More Location
Arkansas Childrens Hospital
Learn More & Join Trial
Efficacy of Mirabegron for Treatment of Non-monosymptomatic Nocturnal Enuresis in Children PHASE3 This phase 3 clinical trial will compare use of individual treatment with m...
Show More Status
Active Not Recruiting
Location
Menoufia faculty of medicine
Learn More & Join Trial
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence PHASE4 The goal of this clinical trial is to compare treatment outcomes between an...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
A Single Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Participants With Renal Insufficiency (MK-4618-014) PHASE1 This study will investigate the impact of impaired renal function on the pl...
Show More Location
Multiple Locations
Learn More & Join Trial
An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). PHASE3 This study is designed to evaluate the safety, tolerability, and efficacy o...
Show More Location
Coastal Clinical Research Inc.
Learn More & Join Trial
A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) PHASE3 This study is designed to evaluate the safety, tolerability, and efficacy o...
Show More Location
Central Alabama Research
Learn More & Join Trial
Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB) N/A This study will evaluate the treatment satisfaction, discontinuation, reaso...
Show More Location
Urology Centers of Alabama
Learn More & Join Trial
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) PHASE3 This study will assess the efficacy of vibegron compared with placebo in me...
Show More Location
Urology Centers of Alabama
Learn More & Join Trial
Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia PHASE3 This study will assess the long-term safety of vibegron when dosed up to 52...
Show More Learn More & Join Trial
To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder PHASE3 Overactive bladder (OAB) is a clinical condition characterized by urgency (...
Show More Location
Asan Medical Center
Learn More & Join Trial